Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized IVX-0142 in mild allergic asthma
NCT00232999Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2005
- Primary completion
- Dec 2005
- Modality
- Bivalent/Multivalent Binders
- Countries
- 1
01
Overview
A Phase 2 trial of IVX-0142 in allergic asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2005; status: completed.
02
Drugs
IVX-0142
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00232999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232999.